← Back to Patent Explorer
US4798724A Expired / Lapsed US ⏱️ 0.0 years remaining

Solid, stable dosage forms with an elastic film coating

Assignee: Novartis Corp
•
Filing: 1986-06-16
•
Granted: 1989-01-17
•
Expires: 2006-06-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Solid, stable dosage forms consisting of a moisture- and temperature-sensitive core prepared from a medicament, or a mixture of medicaments, and excipients, and an elastic film coating which decomposes in aqueous solution, said elastic film coating substantially comprising (a) a water-soluble component consisting of 20-60% of hydroxypropyl cellulose having an average molecular weight of 75,000, and (b) a water-insoluble component consisting of 5-20% of an acrylic resin in the form of (b 1 ) a 70:30 ethyl acrylate/methyl methacrylate copolymer having a molecular weight of 80,000, or (b 2 ) a 30:70 to 70:30 methyl acrylate/methyl methacrylate copolymer having an average molecular weight of 500,000, 20-60% of a lubricant, 0.5-5% of a wetting agent, 0-5% of a plasticizer, and optional additional excipients, and process for the preparation thereof.

Inventors

  • 👤 Satish C. Khanna

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 14:35
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/28; A61K9/2806; A61K9/2833; A61K9/284; A61K9/2846; A61K9/2813; A61K9/286; A61K9/2866

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 199 words
A solid, stable dosage form consisting of a core and an elastic film coating on said core, said core comprising at least one medicament and at least one pharmaceutically acceptable excipient, said core being moisture- or temperature- or both moisture- and temperature-sensitive; said elastic film coating being a coating which decomposes in aqueous solution, which coating comprises (a) 20-60% by weight of a water soluble component, (b) 25.5-80% by weight of a water-insoluble, but dispersable component, and (c) 0.54-5% by weight of further pharmaceutically acceptable adjuvants, said water soluble component consisting of hydroxypropyl cellulose having an average molecular weight of 75,000; said water-insoluble, but dispersable component consisting of (I) 5-20% by weight, based upon the total film coating, of an acrylic resin selected from (A) a 70:30 ethyl acrylate/methyl methacrylate copolymer having a molecular weight of 80,000 and (B) a 30:70-70:30 methyl acrylate/methyl methacrylate copolymer having an average molecular weight of 500,000; (II) 20-60% by weight, based on the total film coating, of a pharmaceutically acceptable lubricant; (III) 0.5-5% by weight, based on the total film coating, of a pharmaceutically acceptable wetting agent; and (IV) 0-5% by weight, based on the total film coating, of a pharmaceutically acceptable plasticiser.
Claim 2
Dependent Claim 199 words
A solid, stable dosage form consisting of a core and an elastic film coating on said core, said core comprising at least one medicament and at least one pharmaceutically acceptable excipient, said core being moisture- or temperature- or both moisture- and temperature-sensitive; said elastic film coating being a coating which decomposes in aqueous solution, which coating comprises (a) 20-60% by weight of a water soluble component, (b) 25.5-80% by weight of a water-insoluble, but dispersable component, and (c) 0.54-5% by weight of further pharmaceutically acceptable adjuvants, said water soluble component consisting of hydroxypropyl cellulose having an average molecular weight of 75,000; said water-insoluble, but dispersable component consisting of (I) 5-20% by weight, based upon the total film coating, of an acrylic resin selected from (A) a 70:30 ethyl acrylate/methyl methacrylate copolymer having a molecular weight of 80,000 and (B) a 30:70-70:30 methyl acrylate/methyl methacrylate copolymer having an average molecular weight of 500,000; (II) 20-60% by weight, based on the total film coating, of a pharmaceutically acceptable lubricant; (III) 0.5-5% by weight, based on the total film coating, of a pharmaceutically acceptable wetting agent; and (IV) 0-5% by weight, based on the total film coating, of a pharmaceutically acceptable plasticiser.
Claim 3
Dependent Claim 46 words
The dosage form of claim 1 wherein said film coating comprises 3- 50% by weight of said hydroxypropyl cellulose; 8-18% by weight of said acrylic resin; 30-50% by weight of said lubricant; 1-2% by weight of said wetting agent; and 0-3% by weight of said plasticiser.
Claim 4
Dependent Claim 18 words
The dosage form of claim 1 wherein said lubricant is selected from magnesium stearate, silica aerogel, and talcum.
Claim 5
Dependent Claim 22 words
The dosage form of claim 1 wherein said wetting agent is selected from glycerylpolyethylene glycol oxystearates and polyoxyethylene sorbitan fatty acid esters.
Claim 6
Dependent Claim 12 words
The dosage form of claim 1 wherein said plasticiser is glycerol triacetate.
Claim 7
Dependent Claim 17 words
The dosage form of claim 1 wherein said further adjuvants are selected from pigments flavorings, and sweeteners.
Claim 8
Dependent Claim 31 words
The dosage form of claim 1 wherein said excipient is pharmaceutically acceptable and selected from ion exchangers, starch, crosslinked starches, crosslinked carboxymethylcellulose, polyacrylic acid, crosslinked polyethylene glycols, natural rubbers, and alginates.
Claim 9
Dependent Claim 21 words
A process for the manufacture of the dosage form of claim 1 comprising coating said core with said elastic film coating.

References Cited (Backward Citations)

JPS449294Y1 Cited
US4361546A Cited
US4308251A Cited
US4486471A Cited
US4606909A Cited
JPS58110943A Cited
US4490322A Cited
US4389393A Cited
US4389393B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-01-17 1992-07-18 1993-01-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-01-17 1996-07-18 1997-01-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-01-17 2000-07-18 2001-01-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag